Immuron (IMRN) Research & Development (2016 - 2025)
Immuron (IMRN) posted Research & Development of -$2.3 million for Q2 2025, down 6331.94% on a QoQ basis from -$35818.6 in Q3 2024, and up 34.97% year-over-year from -$1.7 million in Q2 2024.
Powered by 
Analysis
Immuron (IMRN) Research & Development (2016 - 2025) Analysis & Trends
Immuron has reported Research & Development for 10 years, with the latest figure at -$2.3 million in Q2 2025.
- On a quarterly basis, Research & Development rose 34.97% year-over-year to -$2.3 million in Q2 2025; TTM through Jun 2025 was -$7.6 million, a 112.61% decrease from a year earlier, with the FY2026 full-year figure at -$1.9 million, down 5274.7% from the prior year.
- Research & Development was -$2.3 million for Q2 2025 at Immuron, down from -$35818.6 in the prior quarter.
- The five-year high for Research & Development was $1.5 million in Q4 2022, with the low at -$3.5 million in Q2 2024.
- Average Research & Development over 5 years is -$836295.7, with a median of -$544262.8 recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Research & Development soared 480.18% in 2022, then slumped 2491.9% in 2024.
- Over 5 years, Research & Development stood at $262268.2 in 2021, then jumped by 480.18% to $1.5 million in 2022, then sank by 210.9% to -$1.7 million in 2023, then jumped by 97.88% to -$35818.6 in 2024, then plunged by 6331.94% to -$2.3 million in 2025.
- The last three Research & Development figures came in at -$2.3 million (Q2 2025), -$35818.6 (Q3 2024), and -$3.5 million (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 221.78 Bn | 207.79 Bn | 7.24 Bn | 1.87 Bn |
| 2 | Gilead Sciences | 189.46 Bn | 186.20 Bn | 6.22 Bn | 1.76 Bn |
| 3 | Vertex Pharmaceuticals | 130.47 Bn | 122.62 Bn | 2.84 Bn | 993.80 Mn |
| 4 | Regeneron Pharmaceuticals | 82.64 Bn | 74.65 Bn | 3.93 Bn | 1.63 Bn |
| 5 | Moderna | 72.84 Bn | 67.70 Bn | 52.00 Mn | 651.00 Mn |
| 6 | Argenx Se | 59.64 Bn | 54.46 Bn | 1.37 Bn | -486.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.65 Bn | 30.35 Bn | 992.69 Mn | 413.13 Mn |
| 8 | Biogen | 33.30 Bn | 32.01 Bn | 1.96 Bn | 529.60 Mn |
| 9 | Roivant Sciences | 27.62 Bn | 28.31 Bn | 1.16 Mn | 202.02 Mn |
| 10 | Immuron | 7.31 Mn | -1.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -2.30 Mn |
| Sep 9, 2024 | -35,818.58 |
| Jun 30, 2024 | -3.54 Mn |
| Dec 31, 2023 | -1.69 Mn |
| Jun 30, 2023 | 148,106.67 |
| Dec 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 262,268.17 |
| Jun 30, 2021 | -1.05 Mn |
| Dec 31, 2020 | 358,281.00 |
| Jun 30, 2020 | -772,534.46 |
| Dec 31, 2019 | 531,828.00 |
| Dec 31, 2018 | 1.19 Mn |
| Dec 31, 2017 | -1.18 Mn |
| Dec 31, 2016 | -1.60 Mn |
| Jun 30, 2016 | -2.71 Mn |
API Access
Immuron Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=IMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "IMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=IMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();